Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Nuvectis Pharma, Inc.
Market Cap
$540.02M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$540.91M
Operating Margin
-5150.80%
TTM Avg
-3279.53%
3Y Avg
-6989.17%
5Y Avg
-4746.54%
Market Cap
$536.32M
Operating Margin
-18477.83%
TTM Avg
-130078.39%
3Y Avg
-65039.20%
5Y Avg
-43359.46%
Market Cap
$535.61M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
Market Cap
$533.73M
Operating Margin
-1.90%
TTM Avg
-16.29%
3Y Avg
-781.66%
5Y Avg
-851.82%
Market Cap
$531.02M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$530.71M
Operating Margin
-91.36%
TTM Avg
-296.77%
3Y Avg
-6281.52%
5Y Avg
-4187.68%
Market Cap
$530.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$521.71M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | $540.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shattuck Labs, Inc. (STTK)vs › | $540.91M | -5150.80% | -3279.53% | -6989.17% | -4746.54% |
| ProKidney Corp. (PROK)vs › | $536.32M | -18477.83% | -130078.39% | -65039.20% | -43359.46% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $535.61M | -975.91% | -867.04% | -586.91% | -743.36% |
| Delcath Systems, Inc. (DCTH)vs › | $533.73M | -1.90% | -16.29% | -781.66% | -851.82% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $531.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $530.71M | -91.36% | -296.77% | -6281.52% | -4187.68% |
| Monopar Therapeutics Inc. (MNPR)vs › | $530.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| Immix Biopharma, Inc. (IMMX)vs › | $521.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $559.50M | -29.35% | -5.63% | -52.07% | -106.16% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
